Trials / Completed
CompletedNCT05603130
Epidemiologic Register on Diabetes and COVID-19 in Tunisia
Diabetes and COVID-19 in Tunisia (CoviDTUN)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 811 (actual)
- Sponsor
- Les Laboratoires des Médicaments Stériles · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
CoviDTUN is a multicenter observatory set up by a steering committee to determine the presentation and evolution of diabetes in COVID-19 and study its pathogenesis. The observatory comprises a dataset consisting of routinely collected clinical information anonymously to be entered by the investigator as a participating clinician/researcher. The study will be an opportunity to understand the relationship between COVID-19 and diabetes, to enrich Tunisian data on diabetic and de novo diabetic patients who have contracted COVID-19 and to evaluate the prognostic severity factors for better management of these patients.
Detailed description
It is a multicentric Tunisian observatory for COVID-19 patients. Confirmed COVID-19 patients, treated on an outpatient basis, in containment centers or hospitalized in COVID-19 units were included retrospectively from March 2020 and had continued prospectively til June 2022. The study had selected eligible patient recorded for inclusion by free practice physicians and hospital physicians. General data, medical history, epidemiological characteristics, clinical examination, biological assessment (blood glucose, NFS, CRP, D-dimer, etc.), clinical course and complications were therefore recorded in a structured and anonymized database. Data collection was carried out by DACIMA Clinical Suite® solution, in accordance with the normative and regulatory provisions in force in the management of health data.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | routinely collected clinical information | medical history, epidemiological characteristics, clinical examination, biological assessment (blood glucose, NFS, CRP, D-dimer,etc...) |
Timeline
- Start date
- 2022-03-23
- Primary completion
- 2022-06-30
- Completion
- 2022-10-17
- First posted
- 2022-11-02
- Last updated
- 2022-11-02
Locations
1 site across 1 country: Tunisia
Source: ClinicalTrials.gov record NCT05603130. Inclusion in this directory is not an endorsement.